health π₯ Hospital pricing gaps flagged by FDA chief
Maharashtra FDA chief Tukaram Mundhe pointed out massive price markups on hospital products and medicines. This issue was flagged across Maharashtra, where patients might pay hundreds of percent more than the actual trade price. For instance, an IV infusion set went from a trade price of Rs 11.05 to an MRP of Rs 325. This information gap is a serious public health issue because patients cannot compare costs. A review with clear guidelines is now recommended to the Department of Pharmaceuticals and NPPA.